skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

17 Total results for product and free and sample content found

Scrip, Datamonitor Healthcare

Top 10 Best-Selling Drugs of 2019

By Stephanie Yip 23 Oct 2020

Top 10 Best-Selling Drugs of 2019

In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

Topic Drug Review Diseases

Scrip

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

By Mandy Jackson 02 Jul 2019

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

Private Company Edition: Investments by CIRM, the GHIT fund and the European Investment Bank back early-stage science and treatments for neglected diseases. Also, Versant Ventures raises $700m in two funds. In VC deals, Akero raised $70m, Impel NeuroPharma brought in $67.5m.

Topic Diseases

Datamonitor Healthcare

World AIDS Day 2018 GlaxoSmithKline report

11 Jun 2019

World AIDS Day 2018 GlaxoSmithKline report

PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product forecasts. The full company profile encompasses analysis on corporate strategy, portfolio analysis, pipeline potential, and financial performance.

Topic Diseases Drug Development Landscape Drug Review

Pharma R&D Annual Review 2019

By Ian Lloyd 30 May 2019

 Pharma R&D Annual Review 2019

Pharma R&D Annual Review 2019 is based on the stats and data from from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects.

Topic Clinical Trials Diseases Research & Development Approvals Drug Review

Pharma R&D Annual Review 2019 Infographic

By Ian Lloyd 12 Mar 2019

Pharma R&D Annual Review 2019 Infographic

Get your head in the game with a free download of the Pharma R&D Annual Review 2019 infographic from Informa Pharma Intelligence. This year’s look at the key players and reigning champs of R&D uses a sports theme to present its critical data on the current state of pharma R&D.

Topic Research & Development Drug Development Landscape Diseases Drug Review

Pink Sheet

Sarepta Should Gain Clean Slate With CBER Review of DMD Gene Therapy

By Derrick Gingery 22 Aug 2018

Sarepta Should Gain Clean Slate With CBER Review of DMD Gene Therapy

Sarepta will face a US FDA staff with which it does not have a controversial history, the Center for Biologics Evaluation and Research, likely avoiding the reviewers that evaluated its Duchenne muscular dystrophy treatment Exondys 51.

Topic Diseases

Sitetrove

Sitetrove Roundup – Issue 3 – June 2017

10 Aug 2017

Sitetrove Roundup – Issue 3 – June 2017

The halfway mark for 2017 certainly made a splash with Sitetrove growing by 8,230 investigators across 175 countries from January to June. 

Topic Diseases

Trialtrove

Renal Anemia Infographic

11 Jun 2017

Renal Anemia Infographic

Data for this infographic was drawn from Pharmaprojects, Sitetrove, and Trialtrove, all part of the Informa Pharma Pharma Intelligence suite of intelligence tools.

Topic Diseases

Sitetrove

Sitetrove Roundup A Look Back At 2016

20 Apr 2017

Sitetrove Roundup A Look Back At 2016

A look at 2016! It was a big year for Sitetrove, Pharma Intelligence’s clinical investigator and trial site solution, as it nears 400,000 clinical investigators.

Topic Clinical Trials Diseases

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: